Skip to main content

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

ABOS holding history

Acumen Pharmaceuticals, Inc. in every 13F filed by Deep Track Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABOS overviewAll 13F holders of ABOSFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q4 2021
Holdings of ABOS by Deep Track Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−2,513,044−100.0%Sold outHolders
Q3 20232,513,044$10.4M0.4%−1,403,317−35.8%ReducedHolders
Q2 20233,916,361$18.8M0.9%−35,639−0.9%ReducedHolders
Q1 20233,952,000$16.0M0.7%00.0%UnchangedHolders
Q4 20223,952,000$21.3M0.9%+173,182+4.6%AddedHolders
Q3 20223,778,818$37.9M1.9%+678,818+21.9%AddedHolders
Q2 20223,100,000$14.6M1.0%+500,902+19.3%AddedHolders
Q1 20222,599,098$10.2M0.7%+666,058+34.5%AddedHolders
Q4 20211,933,040$13.1M1.0%–No prior filingHolders